Semaglutide and NT-proBNP in Obesity-Related HFpEF

🏆 Top 20📊 OpenAlex

Most Cited Paper

in Heart Failure Treatment and Management

18 Months Post-Publication

Class of 2026

“Semaglutide and NT-proBNP in Obesity-Related HFpEF”

AuthorsMark C Petrie et al.

Mikhail Kosiborod

JournalJournal of the American College of Cardiology

University of Glasgow

Citations63

DOI10.1016/j.jacc.2024.04.022

A research intelligence initiative by Pepkio

pri.pepkio.com

Topics

semaglutide · NT-proBNP · Obesity-related heart failure with preserved ejection fraction · GLP-1 receptor agonist · STEP-HFpEF trial · STEP-HFpEF DM trial · KCCQ Clinical Summary Score · mechanical unloading · HF pathobiology · baseline NT-proBNP stratification · health status improvement · Body weight change · Heart failure symptoms · physical limitations

Share on X

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-08-20.

Methodology
Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459